Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hip surgery pain block could cut opioid use

NCT ID NCT07540676

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 09, 2026 · Updated 3 times

Summary

This study looked at whether a Quadro-Iliac nerve block can reduce pain after hip surgery. Researchers reviewed 60 patients who had hip surgery, comparing those who got the block plus standard pain relief to those who only used standard pain relief. They measured opioid use, pain scores, and need for extra pain medicine.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Quadro-Iliac Plane Block (local anesthetic injection)
What this could lead to
If effective, this nerve block could offer better pain control after hip surgery, reducing the need for strong painkillers like opioids.
What could go wrong
This is a small, retrospective study, not a large randomized trial. Results may not apply to all patients, and the block may not always work as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

60 people

The number who actually took part.

Started

May 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients (≥18 years) who underwent intertrochanteric femur fracture surgery or total hip arthroplasty under spinal or general anesthesia at our institution during the study period and whose medical records were retrospectively reviewed. Patients were classified according to whether they had received QIPB for postoperative analgesia as part of routine clinical care.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ASA score I-III * Underwent femoral intertrochanteric fracture or total hip replacement surgery Exclusion Criteria: * neurological deficits * mental retardation * history of alcohol or substance use

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Femoral intertrochanteric fracture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Goztepe Prof Dr Suleyman Yalci City Hospital

    Istanbul, 34700, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.